Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05730192
Other study ID # RCT-2022-01
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 10, 2023
Est. completion date December 31, 2024

Study information

Verified date September 2023
Source Odin Medical
Contact Monica Tocchi, MD, PhD
Phone +1 646 933 1025
Email m.tocchi@meditrial.net
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The EAGLE study is a prospective randomized controlled multicenter parallel design trial, for the assessment of clinical performance of the CADDIE device and to confirm that the device performs as expected.


Description:

The EAGLE study will be conducted with a parallel design. Patients who meet the study inclusion/exclusion criteria will be randomized in a 1:1 ratio to receive either computer-aided colonoscopy (CADDIE Arm) using CADDIE or standard colonoscopy without CADe (Control Arm). All resected polyps will be submitted for histologic examination.


Recruitment information / eligibility

Status Recruiting
Enrollment 950
Est. completion date December 31, 2024
Est. primary completion date October 31, 2024
Accepts healthy volunteers No
Gender All
Age group 40 Years and older
Eligibility Inclusion Criteria: 1. Screening or surveillance colonoscopy 2. Age 40 years or older 3. Informed consent Exclusion Criteria: 1. Emergency colonoscopies 2. Inflammatory bowel disease (IBD) 3. Colorectal Cancer (CRC) 4. Previous Colorectal Cancer (CRC) 5. Previous colonic resection 6. Returning for a planned elective therapeutic colonoscopy. 7. Polyposis syndromes (familial adenomatous polyposis) 8. Contraindication for biopsy or polypectomy.

Study Design


Intervention

Device:
CADDIE
A colonoscopy is an examination of the bowels using a colonoscope, or a thin, flexible tube with a light and camera. It can help identify issues like colorectal cancer, polyps, and ulcers.

Locations

Country Name City State
Georgia Israeli-Georgian Medical Research Clinic Healthycore Tbilisi
Germany Sana Klinikum Lichtenberg Berlin
Italy Humanitas Mater Domini Castellanza Varese
Italy Humanitas Catania Catania
Italy Humanitas Research Hospital Milan
Poland H-T. Centrum Medyczne Tychy
Poland Przychodnia Polskiej Fundacji Gastroenterologii Warsaw
Poland The Maria Sklodowska-Curie National Research Institute of Oncology Warsaw
Spain University Hospital "Clinico Lozano Blesa" of Zaragoza Zaragoza
United Kingdom University College Hospital London London

Sponsors (2)

Lead Sponsor Collaborator
Odin Medical Meditrial Europe Ltd.

Countries where clinical trial is conducted

Georgia,  Germany,  Italy,  Poland,  Spain,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Adenoma per colonoscopy (APC) Superiority of CADDIE Arm vs. control. During the procedure/surgery
Primary Positive percent agreement (PPA) Non inferiority of CADDIE Arm vs. control. During the procedure/surgery
See also
  Status Clinical Trial Phase
Recruiting NCT05400122 - Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer Phase 1
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Completed NCT00098787 - Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05425940 - Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer Phase 3
Suspended NCT04595604 - Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery. N/A
Completed NCT03414125 - Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening N/A
Completed NCT02963831 - A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies Phase 1/Phase 2
Recruiting NCT05489211 - Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) Phase 2
Terminated NCT01847599 - Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT03874026 - Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients Phase 2
Active, not recruiting NCT03170960 - Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Phase 1/Phase 2
Completed NCT03167125 - Participatory Research to Advance Colon Cancer Prevention N/A
Completed NCT03181334 - The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation N/A
Recruiting NCT04258137 - Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study N/A
Not yet recruiting NCT05775146 - SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases Phase 2
Recruiting NCT05568420 - A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
Recruiting NCT02972541 - Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer N/A
Completed NCT02876224 - Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors Phase 1